Two awards, one incredible achievement!

Huge congratulations to NU Cancer’s Camille Drai on winning Outstanding Technician of the Year and Early Career Achievement at the Newcastle University Technician Awards 👏

#NUCancer #NewcastleUniversity #TechnicianAwards

🔬 Thank you to Professor Jonathan Higgins for an excellent #NUCancer Seminar on “Dicentric Chromosomes, Genome Instability, and Cancer.”
Great discussions and insights into chromosome rearrangements and cancer biology.

#CancerResearch #NewcastleUniversity #OncologyResearch

🚨New work from the #NUCancer Paediatric Brain Tumour Group shows not all MYC/MYCN-amplified medulloblastomas are the same.

🔹 Some patients face near-incurable disease & need new therapies
🔹 Others can survive long-term with current treatment

#ChildhoodCancer #Medulloblastoma

🏆 #NUCancer Conference 2025: Prize Winner Spotlight

Congratulations to Louisa Taylor, PhD, winner of a Flash Talk Award for her cutting-edge work on high-risk MYC-amplified #medulloblastoma. 🔬💡

#childhoodcancer #childhoodcancerawareness #pediatriccancer #cancerresearch

🎉Congratulations to Dr. Shelby Barnett on receiving the joint EPHAR-EACPT Young Investigator Award in translational Pharmacology.

Great work Shelby! 👏

#NUcancer

Our research explores how genetic abnormalities influence treatment response in MRD-directed protocols, contributing to more refined risk stratification and ultimately improving patient outcomes in Acute Lymphoblastic Leukaemia (ALL).

Excited to present our recent work on the cytogenetic landscape and treatment outcomes in childhood and young adult B-ALL at #NUCancer Conference 2025 at #Newcastle University. Grateful to share MRD-driven risk stratification insights with an inspiring research community. #LeukaemiaResearch